Treatment of experimental sepsis-induced immunoparalysis with TNF

https://doi.org/10.1078/0171-2985-00282Get rights and content

Summary

Following a severe septic abdominal infection induced by sublethal cecal ligation and puncture (CLP) in mice, a phase of depressed immune reactivity occurred two days after CLP characterized by a reduced capacity to produce TNF. To determine whether this reduced TNF production causes immunoparalysis as determined by increased susceptibility to bacterial infection and whether therapeutic TNF substitution can be beneficial during this phase, a super-infection with Salmonella enterica Serovar typhimurium or Listeria monocytogenes was induced two days after sublethal CLP. After CLP a state of true immunoparalysis developed during which Salmonella or Listeria super-infection led to increased lethality paralleled by increased bacterial numbers in spleens and livers. Injection of recombinant human TNF before or at the time of super-infection conferred protection to Salmonella but not to Listeria. In the latter case, the infection mortality was even enhanced. Thus, super-infection during the state of sepsis-induced immunoparalysis leads to increased lethality. TNF substitution during this state of immunoparalysis can be beneficial or deleterious, depending on the location of TNF activity in the animal, timing of TNF administration, or the type of super-infection. These results demonstrate that impaired TNF production capacity can account for some aspects of immunoparalysis, however, diagnostic parameters are required for a safe TNF substitution therapy.

References (24)

  • J.-M. Heinrich et al.

    The essential role of lipopolysaccharide binding (LBP) in protection of mice against a peritoneal Salmonella infection involves the rapid induction of an inflammatory response

    J. Immunol.

    (2001)
  • W.J. Kox et al.

    Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle

    Arch. Intern. Med.

    (1997)
  • Cited by (30)

    • Cardiac steroid ouabain transcriptionally increases human leukocyte antigen DR expression on monocytes

      2021, Steroids
      Citation Excerpt :

      With the exception of these cytokines-based drugs, few small molecules for the treatment of immunoparalysis has been reported. As a matter of fact, small-molecule drug has relatively poor immunoreactivity, extended half-life, and high penetration efficiency across blood–brain barrier when compared with protein drugs [19,20]. Therefore, identification of small-molecule drug that can modulate HLA-DR expression represents a promising trend in the therapy of sepsis-induced immunoparalysis.

    • The effect of Indomethacin and Betamethasone on the cytokine response of human neonatal mononuclear cells to gram-positive bacteria

      2015, Cytokine
      Citation Excerpt :

      Studies in animal models show that TNF plays a critical role in the host defense against bacteria. The pro-inflammatory cytokine is not only required by the innate immune system to initially fight off infections, but also helps resolving the inflammatory response by an ensuing down-regulation of pro-inflammatory cytokines [21,22]. The fact that the inhibition of TNF by TNF antagonists in patients with inflammatory diseases increases the risk of opportunistic infections with a variety of pathogens [23] underlines the importance of this cytokine in the host defense against bacteria and other pathogens.

    • Emerging Therapeutic Targets of Sepsis-Associated Acute Kidney Injury

      2015, Seminars in Nephrology
      Citation Excerpt :

      Trials for these agents are in various stages (Table 2). Another novel approach has been based on the finding that late sepsis-related deaths often appear to be associated with evidence of immune suppression and dysfunction.10,136 Thus, patients who survive the initial proinflammatory stage may enter an anti-inflammatory phase with variable degrees of immunoparalysis.

    • Sepsis, apoptosis and complement

      2008, Biochemical Pharmacology
      Citation Excerpt :

      It should also be noted that approximately 50% of humans with sepsis have gram positive bacterial pneumonia [1–3]. While lipopolysaccharide (LPS) has been speculated to cause harmful outcomes, there is other evidence (in TLR4−/−, CD14−/−, and LPS-binding protein−/− mice) suggesting that, at least in the setting of CLP, LPS may not be a major determinant in the adverse outcomes [19–21]. All three pathways of complement activation converge to generate the “C3 convertase”, which cleaves C3 into a small (C3a) and a large (C3b) fragmentation product (Fig. 1).

    • Advances in sepsis research derived from animal models

      2007, International Journal of Medical Microbiology
    View all citing articles on Scopus
    View full text